Importance Hepatocellular carcinoma (HCC) is the sixth most common malignancy and
fourth leading cause of cancer-related death worldwide. Recent advances in systemic and …

Introduction The treatment landscape of hepatocellular carcinoma (HCC) has significantly
changed over the last 5 years with multiple options in the frontline, second line, and beyond …

Importance Most patients with hepatocellular carcinoma (HCC) are diagnosed with
advanced disease not eligible for potentially curative therapies; therefore, new treatment …

Hepatocellular carcinoma (HCC) is the most common primary liver cancer and the second
most frequent cause of cancer-related mortality worldwide. The multikinase inhibitor …

Angiogenesis is defined as the formation of new blood vessels from preexisting vessels and
has been characterized as an essential process for tumor cell proliferation and viability. This …

Abstract The Asia-Pacific Primary Liver Cancer Expert (APPLE) Consensus Statement on
the treatment strategy for patients with intermediate-stage hepatocellular carcinoma (HCC) …

This study investigated the therapeutic effects of the phytochemical crocin alone or in
combination with sorafenib both in rats chemically induced with hepatocellular carcinoma …

Transarterial chemoembolization (TACE) is the only guideline-recommended global
standard of care for intermediate-stage hepatocellular carcinoma (HCC). However, TACE is …

Hepatocellular carcinoma (HCC) is a chronic liver disease that is highly fatal if not detected
and treated early. The incidence and death rate of HCC have been increasing in recent …

Portal vein tumor thrombus (PVTT) is very common, and it plays a major role in the
prognosis and clinical staging of hepatocellular carcinoma (HCC). We have published the …